C hristian Angermayer is a German serial entrepreneur and investor who has built a diverse business empire through his family office and investment firm, Apeiron Investment Group. He is known for his wide-ranging interests and his focus on investing in what he considers to be the next frontiers of technology and science, including longevity, cryptocurrencies, and psychedelic medicine.

Angermayer has been an early and significant investor in several high-profile companies. He was an early backer of the biotech company BioNtech, which later co-developed the Pfizer-BioNTech COVID-19 vaccine. He has also founded and invested in numerous companies in the emerging field of psychedelic-based mental health treatments, such as Atai Life Sciences and Compass Pathways. His investment strategy is characterized by bold bets on new and often unconventional technologies that he believes will have a profound impact on humanity.